Full-Time

Strategic Program Manager

Confirmed live in the last 24 hours

Cleerly

Cleerly

51-200 employees

AI platform for cardiovascular disease diagnosis

Compensation Overview

$127k - $142kAnnually

Senior

New York, NY, USA

Some roles require you to be on-site in a location.

Category
Project Management
Business & Strategy
Requirements
  • Bachelor’s Degree; Master’s Degree preferred
  • 5+ years’ experience managing multiple large-scale projects
  • PMP, PMI Certification, Lean Six Sigma, or Six Sigma
  • Ability to communicate and interact with Senior Leadership and external executive audiences
  • Excellent written, oral, and interpersonal skills
  • Proficiency in project management tools, frameworks, and reporting
  • Strong analytical, critical thinking, creative problem solving, judgment, and client management skills
  • Ability to maintain confidentiality, tact, and diplomacy
  • Exceptional interpersonal skills and understanding of group dynamics
  • Experience in healthcare, SaaS, or Consulting required
Responsibilities
  • Set up the internal operations and program architecture for new programs in collaboration with the Senior Leadership team.
  • Manage commercial programs from inception to completion, ensuring alignment with company goals in collaboration with senior program managers.
  • Develop and maintain project roadmaps, timelines, and milestones to ensure on-time delivery.
  • Serve as a central point of coordination between sales, marketing, operations, and customer success teams to streamline execution.
  • Establish and track KPIs to measure program effectiveness and provide regular updates to leadership.
  • Implement and improve project management frameworks, tools, and best practices to enhance efficiency.
  • Identify and mitigate risks and roadblocks that could impact project success.
  • Drive continuous process improvements and standardization across the commercial organization.
  • Support change management initiatives, ensuring smooth adoption of new processes and technologies.
  • Facilitate communication, reporting, and presentations for senior leadership.
Desired Qualifications
  • Master’s Degree preferred

Cleerly Health focuses on improving the diagnosis and treatment of heart disease through its digital healthcare platform. The company utilizes artificial intelligence to analyze coronary computed tomography angiography (CCTA) imaging, which helps clinicians detect atherosclerosis, a condition characterized by plaque buildup in the arteries, at an earlier stage. Cleerly's platform converts complex imaging data into clear insights, allowing healthcare providers to create personalized treatment plans for their patients. This approach stands out from competitors by offering a more detailed evaluation of heart disease, including the ability to analyze and quantify different types of plaque, which aids in accurately assessing a patient's risk of heart attack. Cleerly's goal is to enhance patient outcomes and provide financial benefits to healthcare providers through its digital cardiovascular care management program.

Company Size

51-200

Company Stage

Series C

Total Funding

$406.4M

Headquarters

New York City, New York

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Cleerly raised $106M to scale commercial growth and clinical evidence generation.
  • The FDA's Breakthrough Device Designation supports Cleerly's innovative CAD Staging System.
  • AI in medical imaging market growth offers expansion opportunities for Cleerly.

What critics are saying

  • Increased competition from AI-driven cardiovascular imaging companies may impact Cleerly's market share.
  • Reliance on FDA approvals poses risks if future innovations face regulatory delays.
  • Significant funding needs could strain resources if future rounds are unsuccessful.

What makes Cleerly unique

  • Cleerly integrates AI with coronary CT angiography for early atherosclerosis detection.
  • The company offers personalized treatment plans through its AI-based digital care platform.
  • Cleerly's FDA-cleared solutions provide actionable insights for coronary artery disease phenotyping.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, and vision plans

Stock Options

401(k) matching program

Company wide holidays

Self-managed PTO

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-7%

2 year growth

-1%
Cardiovascular Business
Mar 4th, 2025
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations

Denver-based Cleerly, known for using AI to evaluate coronary CT angiography (CCTA) images, has joined forces with San Francisco-based Bunkerhill Health, pioneers in AI-powered early detection software, to expand the reach of both companies' FDA-cleared solutions.

Times of Innovation
Dec 6th, 2024
AI Startup Cleerly Raises $106M for Heart Disease Detection

Cleerly's recent funding round was led by significant venture capital firms, including GGV Capital and RRE Ventures, among others, reflecting a growing investor interest in health tech solutions.

Automation Tools
Dec 5th, 2024
Cleerly Secures $106M in Funding from Insight Partners for AI-Powered Heart Health Early Detection

Cleerly, a cardiovascular imaging startup, has announced a significant $106 million Series C extension round led by Insight Partners, with participation from Battery Ventures.

TechCrunch
Dec 4th, 2024
Cleerly raises $106M from Insight Partners for AI heart health early detection | TechCrunch

Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that

Finsmes
Dec 4th, 2024
Cleerly Secures $106M for Growth

Cleerly, a Denver-based cardiovascular imaging company, raised $106 million in funding. The round was led by Insight Partners and included Battery Ventures, along with existing investors. The funds will be used to scale commercial growth and clinical evidence generation. Cleerly, led by CEO James K. Min, MD, offers FDA-cleared AI-driven solutions for coronary artery disease phenotyping using advanced CT imaging.